Dan W. Gladney

Dan W. Gladney is CEO at EnteroMedics Inc (ETRM). They have made 3 open-market trades across 2 companies since 2015, most recently 2021-09-10.

CIK 0001224184

Get an email the next time Dan W. Gladney files.Follow for free

2 open-market purchases totalling $257K since 2015, against 1 sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
RSLS	483,922	$1.9M
ETRM	134,745	$276K
Total		$2.2M

Shares reported on the most recent Form 4, priced at the 2021-09-17 close.

Grade by Ticker

Get an email the next time Dan W. Gladney files

Free account. One email when the next filing comes in.

Follow Dan W. Gladney for free

Buy Track Record

Filings2

Only 2 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

No scored decision-sell filings

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.

Volume by Type

SOpen-Market Sale

$598K

1 filings

POpen-Market Purchase

$257K

2 filings

AAward/Grant

1 filings

Companies

Trade History

3 total

RSLSSELL

$598K

2021-09-107d: -8.9%

Top TradeOpportunistic Sell

•Decreased holdings by 41%
•2 other insiders also sold in last 30 days
+1 more

ETRMBUY

$135K

2015-11-127d: -43.0%

Unusually Large TradeOpportunistic Buy

ETRMBUY

$122K

2015-05-167d: -21.4%

Massive Holdings Increase (>100%)Opportunistic BuyFirst-Time Buyer

•Increased holdings by 169%

Ticker	Type	Traded	Filed	Price	Value	7d Stock	30d Stock	90d Stock
RSLS	SELL	2021-09-10	2021-09-17	$2.99	$598K	-8.9%	+3.8%	-28.0%
ETRM	BUY	2015-11-12	2015-11-16	$0.18	$135K	-43.0%	-11.4%	-45.5%
ETRM	BUY	2015-05-16	2016-05-18	$0.72	$122K	-21.4%	-39.2%	-75.4%

Related Insiders

Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.